These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33872197)

  • 1. A Multicenter, Blinded, Randomized Controlled Clinical Trial Evaluating the Effect of Omega-3-Rich Fish Skin in the Treatment of Chronic, Nonresponsive Diabetic Foot Ulcers.
    Lullove EJ; Liden B; Winters C; McEneaney P; Raphael A; Lantis Ii JC
    Wounds; 2021 Jul; 33(7):169-177. PubMed ID: 33872197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers.
    Zelen CM; Orgill DP; Serena T; Galiano R; Carter MJ; DiDomenico LA; Keller J; Kaufman J; Li WW
    Int Wound J; 2017 Apr; 14(2):307-315. PubMed ID: 27073000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-adrenergic antagonist for the healing of chronic diabetic foot ulcers: study protocol for a prospective, randomized, double-blinded, controlled and parallel-group study.
    Kaur R; Tchanque-Fossuo C; West K; Hadian Y; Gallegos A; Yoon D; Ismailyan L; Schaefer S; Dahle SE; Isseroff RR
    Trials; 2020 Jun; 21(1):496. PubMed ID: 32513257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Multinational, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy of Cyclical Topical Wound Oxygen (TWO2) Therapy in the Treatment of Chronic Diabetic Foot Ulcers: The TWO2 Study.
    Frykberg RG; Franks PJ; Edmonds M; Brantley JN; Téot L; Wild T; Garoufalis MG; Lee AM; Thompson JA; Reach G; Dove CR; Lachgar K; Grotemeyer D; Renton SC;
    Diabetes Care; 2020 Mar; 43(3):616-624. PubMed ID: 31619393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Final efficacy and cost analysis of a fish skin graft vs standard of care in the management of chronic diabetic foot ulcers: a prospective, multicenter, randomized controlled clinical trial.
    Lantis Ii JC; Lullove EJ; Liden B; McEneaney P; Raphael A; Klein R; Winters C; Huynh RN
    Wounds; 2023 Apr; 35(4):71-79. PubMed ID: 37023475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the effect of omega-3-rich fish skin in the treatment of chronic, nonresponsive diabetic foot ulcers: penultimate analysis of a multicenter, prospective, randomized controlled trial.
    Lullove EJ; Liden B; McEneaney P; Raphael A; Klein R; Winters C; Lantis Ii JC
    Wounds; 2022 Apr; 34(4):E34-E36. PubMed ID: 35797557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-centre prospective randomised controlled clinical trial to evaluate a bioactive split thickness skin allograft vs standard of care in the treatment of diabetic foot ulcers.
    Armstrong DG; Galiano RD; Orgill DP; Glat PM; Carter MJ; Di Domenico LA; Reyzelman AM; Zelen CM
    Int Wound J; 2022 May; 19(4):932-944. PubMed ID: 35080127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A purified reconstituted bilayer matrix shows improved outcomes in treatment of non-healing diabetic foot ulcers when compared to the standard of care: Final results and analysis of a prospective, randomized, controlled, multi-centre clinical trial.
    Armstrong DG; Orgill DP; Galiano RD; Glat PM; Kaufman JP; Carter MJ; DiDomenico LA; Zelen CM
    Int Wound J; 2024 Apr; 21(4):e14882. PubMed ID: 38606794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faster Than Projected Healing in Chronic Venous and Diabetic Foot Ulcers When Treated with Intact Fish Skin Grafts Compared to Expected Healing Times for Standard of Care: An Outcome-Based Model from a Swiss Hospital.
    Zehnder T; Blatti M
    Int J Low Extrem Wounds; 2022 May; ():15347346221096205. PubMed ID: 35546101
    [No Abstract]   [Full Text] [Related]  

  • 10. Topical oxygen therapy in the treatment of diabetic foot ulcers: a multicentre, open, randomised controlled clinical trial.
    Serena TE; Bullock NM; Cole W; Lantis J; Li L; Moore S; Patel K; Sabo M; Wahab N; Price P
    J Wound Care; 2021 May; 30(Sup5):S7-S14. PubMed ID: 33979229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acellular Fish Skin Graft Use for Diabetic Lower Extremity Wound Healing: A Retrospective Study of 58 Ulcerations and a Literature Review.
    Michael S; Winters C; Khan M
    Wounds; 2019 Oct; 31(10):262-268. PubMed ID: 31730505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord (EpiCord) allograft for the treatment of diabetic foot ulcers.
    Tettelbach W; Cazzell S; Sigal F; Caporusso JM; Agnew PS; Hanft J; Dove C
    Int Wound J; 2019 Feb; 16(1):122-130. PubMed ID: 30246926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of an aseptically processed, dehydrated human amnion and chorion membrane improves likelihood and rate of healing in chronic diabetic foot ulcers: A prospective, randomised, multi-centre clinical trial in 80 patients.
    DiDomenico LA; Orgill DP; Galiano RD; Serena TE; Carter MJ; Kaufman JP; Young NJ; Jacobs AM; Zelen CM
    Int Wound J; 2018 Dec; 15(6):950-957. PubMed ID: 30019528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Prospective, Randomized, Multicenter, Controlled Evaluation of the Use of Dehydrated Amniotic Membrane Allograft Compared to Standard of Care for the Closure of Chronic Diabetic Foot Ulcer.
    Snyder RJ; Shimozaki K; Tallis A; Kerzner M; Reyzelman A; Lintzeris D; Bell D; Rutan RL; Rosenblum B
    Wounds; 2016 Mar; 28(3):70-7. PubMed ID: 26978860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multi-centre, single-blinded randomised controlled clinical trial evaluating the effect of resorbable glass fibre matrix in the treatment of diabetic foot ulcers.
    Armstrong DG; Orgill DP; Galiano RD; Glat PM; DiDomenico LA; Carter MJ; Zelen CM
    Int Wound J; 2022 May; 19(4):791-801. PubMed ID: 34418302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Prospective, Randomized, Blinded, Controlled Trial Comparing Transdermal Continuous Oxygen Delivery to Moist Wound Therapy for the Treatment of Diabetic Foot Ulcers.
    Driver VR; Reyzelman A; Kawalec J; French M
    Ostomy Wound Manage; 2017 Apr; 63(4):12-28. PubMed ID: 28448266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter retrospective study comparing a polylactic acid CAMP with intact fish skin graft or a collagen dressing in the management of diabetic foot ulcers and venous leg ulcers.
    Liden BA; Liu T; Regulski M; Foster M; DeLeon R; Palazzi G; Ramirez-GarciaLuna JL
    Wounds; 2024 Sep; 36(9):297-302. PubMed ID: 39378347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
    Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
    Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dehydrated Amnion Chorion Membrane versus standard of care for diabetic foot ulcers: a randomised controlled trial.
    Cazzell SM; Caporusso J; Vayser D; Davis RD; Alvarez OM; Sabolinski ML
    J Wound Care; 2024 Jul; 33(Sup7):S4-S14. PubMed ID: 38973638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical Erythropoietin Accelerates Wound Closure in Patients with Diabetic Foot Ulcers: A Prospective, Multicenter, Single-Blind, Randomized, Controlled Trial.
    Hamed S; Ullmann Y; Belokopytov M; Shoufani A; Kabha H; Masri S; Feldbrin Z; Kogan L; Kruchevsky D; Najjar R; Liu PY; Kerihuel JC; Akita S; Teot L
    Rejuvenation Res; 2021 Aug; 24(4):251-261. PubMed ID: 33504262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.